KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Return on Assets (2016 - 2025)

Historic Return on Assets for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q3 2025 value amounting to 0.25%.

  • CRISPR Therapeutics AG's Return on Assets fell 1300.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.18% for FY2024, which is 1000.0% down from last year.
  • According to the latest figures from Q3 2025, CRISPR Therapeutics AG's Return on Assets is 0.25%, which was down 1300.0% from 0.24% recorded in Q2 2025.
  • Over the past 5 years, CRISPR Therapeutics AG's Return on Assets peaked at 0.18% during Q2 2021, and registered a low of 0.28% during Q4 2022.
  • Over the past 5 years, CRISPR Therapeutics AG's median Return on Assets value was 0.18% (recorded in 2024), while the average stood at 0.12%.
  • As far as peak fluctuations go, CRISPR Therapeutics AG's Return on Assets soared by 3500bps in 2021, and later crashed by -4300bps in 2022.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Return on Assets stood at 0.14% in 2021, then tumbled by -309bps to 0.28% in 2022, then surged by 70bps to 0.09% in 2023, then plummeted by -112bps to 0.18% in 2024, then tumbled by -37bps to 0.25% in 2025.
  • Its Return on Assets was 0.25% in Q3 2025, compared to 0.24% in Q2 2025 and 0.19% in Q1 2025.